RB

Ranjna Bhan

Active Director Director DIN 02358120
DIN 02358120 First appointment Dec 2005 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2005
Shareholding value •••• Premium profile

About Ranjna Bhan

Data last updated:

Ranjna Bhan is a Director at Recova Biotech Private Limited (since 2005). The company operates in Trading. Recova Biotech Private Limited reported revenue of ₹49.3 Lakh (FY 2025).

DIN 02358120
Primary Designation Director
Industry Trading
First Appointment 07 Dec 2005
Oldest Company Age 20 yrs
Largest company Recova Biotech Private Limited · ₹49.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Recova Biotech Private Limited U51397JK2005PTC002594
Director07 Dec 20052005₹49.3 Lakh (FY 2025)Active

Board colleagues of Ranjna Bhan

NameDINCompanyDesignation
Rajan Bhan02358104Recova Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Recova Biotech Private Limited
Premium access

Shareholding and investment profile for Ranjna Bhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjna Bhan

Ranjna Bhan currently holds 1 directorship: Recova Biotech Private Limited (Director, since 07 Dec 2005, revenue ₹49.3 Lakh (FY 2025)).

Ranjna Bhan was first appointed on 07 Dec 2005 as Director at Recova Biotech Private Limited.

The current boards of Ranjna Bhan's companies include Rajan Bhan (Recova Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available